HK1081987A1 - Flavivirus vaccine delivery system - Google Patents

Flavivirus vaccine delivery system

Info

Publication number
HK1081987A1
HK1081987A1 HK06102065A HK06102065A HK1081987A1 HK 1081987 A1 HK1081987 A1 HK 1081987A1 HK 06102065 A HK06102065 A HK 06102065A HK 06102065 A HK06102065 A HK 06102065A HK 1081987 A1 HK1081987 A1 HK 1081987A1
Authority
HK
Hong Kong
Prior art keywords
delivery system
vaccine delivery
flavivirus vaccine
flavivirus
vaccine
Prior art date
Application number
HK06102065A
Other languages
English (en)
Inventor
Alexander A Khromykh
Andreas Suhrbier
Original Assignee
Replikun Biotech Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPR9093A external-priority patent/AUPR909301A0/en
Priority claimed from AU2002950974A external-priority patent/AU2002950974A0/en
Application filed by Replikun Biotech Pty Ltd filed Critical Replikun Biotech Pty Ltd
Publication of HK1081987A1 publication Critical patent/HK1081987A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2770/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
    • C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK06102065A 2001-11-26 2006-02-17 Flavivirus vaccine delivery system HK1081987A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPR9093A AUPR909301A0 (en) 2001-11-26 2001-11-26 Flavivirus vaccine system
AU2002950974A AU2002950974A0 (en) 2002-07-29 2002-07-29 Flavivirus vaccine system
PCT/AU2002/001598 WO2003046189A1 (en) 2001-11-26 2002-11-26 Flavivirus vaccine delivery system

Publications (1)

Publication Number Publication Date
HK1081987A1 true HK1081987A1 (en) 2006-05-26

Family

ID=25646850

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06102065A HK1081987A1 (en) 2001-11-26 2006-02-17 Flavivirus vaccine delivery system

Country Status (8)

Country Link
US (1) US20060204523A1 (xx)
EP (1) EP1461441A4 (xx)
JP (1) JP2005510244A (xx)
CN (1) CN100392087C (xx)
CA (1) CA2467397A1 (xx)
HK (1) HK1081987A1 (xx)
NZ (1) NZ533237A (xx)
WO (1) WO2003046189A1 (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1593738A4 (en) * 2003-01-30 2006-05-31 Shanghai Tengen Biomedical Co VIRUSELY PARTICULATE VACCINE WITH RECOMBINANT DENGUEVIRUS REPLICANT AS ITS SUPPORT
AU2003902842A0 (en) * 2003-06-06 2003-06-26 The University Of Queensland Flavivirus replicon packaging system
AU2004245578B2 (en) * 2003-06-06 2008-10-30 Replikun Biotech Pty Ltd Flavivirus replicon packaging system
CN1304579C (zh) * 2003-07-21 2007-03-14 上海天甲生物医药有限公司 重组的以黄热病病毒为载体的疫苗
WO2005042014A1 (en) * 2003-10-29 2005-05-12 The University Of Queensland West nile virus vaccine
US8252574B2 (en) 2006-02-27 2012-08-28 The Board Of Regents Of The University Of Texas System Pseudoinfectious flavivirus and uses thereof
SG188891A1 (en) 2008-03-14 2013-04-30 Sanofi Pasteur Biologics Co Replication-defective flavivirus vaccines and vaccine vectors
EP2408477A4 (en) * 2009-03-16 2013-03-27 Sanofi Pasteur Biologics Llc REPLICATION DEFECTS FLAVIVIRUS VACCINE VACCINATORS AGAINST RESPIRATORY SYNZYTIAL VIRUS
BR112013000391B8 (pt) * 2010-07-06 2022-10-04 Novartis Ag Composição de emulsão catiônica de óleo em água e seu uso
EP2714071B1 (en) * 2011-05-24 2019-07-10 BioNTech RNA Pharmaceuticals GmbH Individualized vaccines for cancer
RS64230B1 (sr) 2011-05-24 2023-06-30 BioNTech SE Individualizovane vakcine protiv kancera
WO2013019603A2 (en) * 2011-07-29 2013-02-07 Inovio Pharmaceuticals, Inc. Linear expression cassettes and uses thereof
WO2015118146A1 (en) 2014-02-10 2015-08-13 Univercells Nv System, apparatus and method for biomolecules production
US10548959B2 (en) * 2015-09-23 2020-02-04 Massachusetts Institute Of Technology Compositions and methods for modified dendrimer nanoparticle delivery
CA3053289A1 (en) * 2017-02-14 2018-08-23 Xuping XIE Live attenuated zika virus with 3'utr deletion, vaccine containing and use thereof
KR20220124171A (ko) * 2019-12-03 2022-09-13 더 카운실 오브 더 퀸즐랜드 인스티튜트 오브 메디컬 리서치 결손간섭입자

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6184024B1 (en) * 1988-07-14 2001-02-06 The United States Of America As Represented By The Department Of Health And Human Services Chimeric and/or growth-restricted flaviviruses
IL131600A0 (en) * 1997-02-28 2001-01-28 Ora Vax Inc Chimeric flavivirus vaccines
US6893866B1 (en) * 1997-11-28 2005-05-17 The Crown In The Right Of The Queensland Department Of Health Flavivirus expression and delivery system
JP2002500003A (ja) * 1997-11-28 2002-01-08 ザ・クラウン・イン・ザ・ライト・オヴ・ザ・クイーンズランド・デパートメント・オヴ・ヘルス フラビウイルスの発現および送達のシステム
AU774045B2 (en) * 1998-09-02 2004-06-17 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Dengue viruses that are replication defective in mosquitos for use as vaccines
FR2794865B1 (fr) * 1999-06-09 2003-04-18 Pasteur Institut Methode de detection precoce des flavivirus et ses applications
SK288290B6 (sk) * 1999-08-09 2015-07-01 Sandoz Ag Vektor na expresiu heterológnych proteínov v bakteriálnej hostiteľskej bunke, bakteriálna hostiteľská bunka a spôsob produkcie požadovaného heterológneho polypeptidu
US6589531B1 (en) * 2000-01-21 2003-07-08 The Regents Of The University Of California Recombinant yellow fever virus and method of use thereof
PT2278012E (pt) * 2000-02-16 2015-11-30 Univ Mahidol Quimeras imunogénicas do vírus do dengue 2
US6783939B2 (en) * 2000-07-07 2004-08-31 Alphavax, Inc. Alphavirus vectors and virosomes with modified HIV genes for use in vaccines

Also Published As

Publication number Publication date
CA2467397A1 (en) 2003-06-05
CN100392087C (zh) 2008-06-04
EP1461441A4 (en) 2006-02-22
JP2005510244A (ja) 2005-04-21
NZ533237A (en) 2005-11-25
US20060204523A1 (en) 2006-09-14
CN1671851A (zh) 2005-09-21
WO2003046189A1 (en) 2003-06-05
EP1461441A1 (en) 2004-09-29

Similar Documents

Publication Publication Date Title
HK1081987A1 (en) Flavivirus vaccine delivery system
HUP0401438A3 (en) Drug delivery system
AU5532601A (en) Targeted vaccine delivery systems
GB2380635B (en) Short message delivery system
HK1077523A1 (en) Proliposomal drug delivery system
HUP0402471A3 (en) Vaccine
GB0407935D0 (en) Vaccine
HUP0402259A3 (en) Vaccines
EP1411905A4 (en) DELIVERY SYSTEM WITH DELAYED RELEASE
HUP0303372A3 (en) Vaccine
EP1423141A4 (en) VACCINE
EP1406598A4 (en) DEVICE FOR DRUG DELIVERY BY THE LYMPHATIC SYSTEM
IL159875A0 (en) Zero order controlled drug delivery system
GB0121171D0 (en) Vaccine
GB0103877D0 (en) Novel Drug Delivery system
GB0029843D0 (en) Drug delivery system
GB0130307D0 (en) Air delivery system
GB0118078D0 (en) Intraosseous anaesthesia delivery system
GB0105238D0 (en) Vaccines
GB0102725D0 (en) Medical delivery system
GB0113857D0 (en) Delivery system
AUPR909301A0 (en) Flavivirus vaccine system
GB0105958D0 (en) Delivery system
GB0115136D0 (en) Drug delivery system
GB0112326D0 (en) Drug delivery system

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20121126